---
title: Calculating the Real ROI of GLP-1 Medications | Insights for Managing Costs | WeightWatchers for Business
description: "Obesity and related comorbid conditions like type 2 diabetes, cardiovascular\ndisease, and musculoskeletal concerns have been increasing in prevalence and\nseverity in recent years. The costs of treating obesity and its related conditions are\nalso on the rise for employers, driven by medical and pharmacy claims as well as\nunplanned absences and lost productivity."
image: https://business.weightwatchers.com/hubfs/WeightWatchers%20For%20Business%20Assets%20+%20Files%202024/WWHS%20Site%20Assets%20(Developer%20Files)/Custom%20Thumbnails/The%20Real%20ROI%20of%20GLP-1%20Medications%20White%20Paper%20Cover.png
---

[![WWatchers\_RGB\_Horiz\_Blu](https://business.weightwatchers.com/hubfs/Logos/WW_ForBusiness_Blurple.svg "WWatchers_RGB_Horiz_Blu")](https://business.weightwatchers.com/?hsLang=en)

- Resources 
    - [Blog](https://business.weightwatchers.com/perspectives)
    - [Content Library](https://business.weightwatchers.com/resources)

[Let's Talk](https://business.weightwatchers.com/contact-us-old2?hsLang=en)

## ![ww-eyebrow-white-paper-apple](https://business.weightwatchers.com/hs-fs/hubfs/WeightWatchers%20For%20Business%20Assets%20+%20Files%202024/WWHS%20Site%20Assets%20(Developer%20Files)/Asset%20Name%20Eyebrows/ww-eyebrow-white-paper-apple.png?width=166&height=36&name=ww-eyebrow-white-paper-apple.png)

 

## The real ROI of GLP-1 medications

GLP-1 medications offer an exciting treatment option for obesity. But organizations are grappling with how to manage the costs. Working with a leading actuarial firm, we dug into the numbers to calculate the real ROI of GLP-1 medications. 

Download the report to uncover the latest insights on:

- The only third-party-validated GLP-1 ROI for employers    
  The value-driving role for behavioral programs
- A comparison of defensive and offensive ROI models
- A closer look at the potential savings for managed vs. unmanaged care

![The Real ROI of GLP-1 Medications White Paper Cover](https://business.weightwatchers.com/hs-fs/hubfs/WeightWatchers%20For%20Business%20Assets%20+%20Files%202024/WWHS%20Site%20Assets%20(Developer%20Files)/Custom%20Thumbnails/The%20Real%20ROI%20of%20GLP-1%20Medications%20White%20Paper%20Cover.png?width=250&height=323&name=The%20Real%20ROI%20of%20GLP-1%20Medications%20White%20Paper%20Cover.png "The Real ROI of GLP-1 Medications White Paper Cover")

## Get your copy today

×

<https://www.linkedin.com/showcase/weight-watchers-health-solutions/>

- Resources 
    - [Blog](https://business.weightwatchers.com/perspectives?hsLang=en)
    - [Content Library](https://business.weightwatchers.com/resources?hsLang=en)

- [Privacy Policy](https://www.weightwatchers.com/us/privacy/policy)
- [Terms and Conditions](https://www.weightwatchers.com/us/termsandconditions)
- [Health Privacy Statement](https://www.weightwatchers.com/us/hps)
- [Do Not Sell My Personal Info](https://www.weightwatchers.com/us/en/preferences/donotsell-update)

The WW Logo, WeightWatchers, Points, and ZeroPoint are trademarks of WW International, Inc. ©2026 WW International, Inc. All rights reserved.